Literature DB >> 23487506

Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.

Kathryn A Bailey1, Kathleen Wallace, Lisa Smeester, Sheau-Fung Thai, Douglas C Wolf, Stephen W Edwards, Rebecca C Fry.   

Abstract

Chronic exposure to drinking water contaminated with inorganic arsenic (iAs) is associated with an increased risk of urinary bladder (UB) cancers in humans. The exact role of specific iAs metabolite(s) in As-mediated carcinogenesis remains largely unknown. Experimental evidence suggests that trivalent arsenicals, namely arsenite (iAsIII) and two of its metabolites, monomethylarsonous acid (MMAIII) and dimethylarsinous acid (DMAIII), are possible proximate UB carcinogens. Here, we used a transcriptomics approach to examine perturbed molecular pathways in a human urothelial cell line (UROtsa) after short-term exposure to iAsIII, MMAIII and DMAIII. Molecular pathways containing genes that encode proteins implicated in UB cancer development were perturbed by both MMAIII and DMAIII. These pathways included those of the extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase (ERK 1/2 MAPK) and nuclear factor kappa beta (NF-κB). Together, these results may inform the current understanding of effects in the UB induced by acute As exposure and the relationship of these effects with As-mediated carcinogenesis.

Entities:  

Keywords:  Arsenite; DMAIII; MMAIII; UROtsa; dimethylarsinous acid; extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase; gene expression; inflammation; microarray; monomethylarsonous acid; nuclear factor kappa beta; urinary bladder cancer

Year:  2012        PMID: 23487506      PMCID: PMC3593739     

Source DB:  PubMed          Journal:  J Can Res Updates


  86 in total

1.  Global impacts of geogenic arsenic: a medical geology research case.

Authors:  Jose A Centeno; Chin-Hsiao Tseng; Gijsbert B Van der Voet; Robert B Finkelman
Journal:  Ambio       Date:  2007-02       Impact factor: 5.129

2.  Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells.

Authors:  C Escudero-Lourdes; T Wu; J M Camarillo; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2011-10-10       Impact factor: 4.219

Review 3.  The tumor microenvironment: key to early detection.

Authors:  Edgardo V Ariztia; Catherine J Lee; Radhika Gogoi; David A Fishman
Journal:  Crit Rev Clin Lab Sci       Date:  2006       Impact factor: 6.250

Review 4.  Methylation of inorganic arsenic in different mammalian species and population groups.

Authors:  M Vahter
Journal:  Sci Prog       Date:  1999       Impact factor: 2.774

Review 5.  Selective COX-1 inhibition: A therapeutic target to be reconsidered.

Authors:  M G Perrone; A Scilimati; L Simone; P Vitale
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 6.  Arsenic-induced bladder cancer in an animal model.

Authors:  Samuel M Cohen; Takamasa Ohnishi; Lora L Arnold; X Chris Le
Journal:  Toxicol Appl Pharmacol       Date:  2006-10-17       Impact factor: 4.219

7.  Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis.

Authors:  Kylee E Eblin; Tiffany G Bredfeldt; Sarah Buffington; A Jay Gandolfi
Journal:  Toxicol Sci       Date:  2006-11-08       Impact factor: 4.849

8.  Speciation of arsenic in biological samples.

Authors:  Badal Kumar Mandal; Yasumitsu Ogra; Kazunori Anzai; Kazuo T Suzuki
Journal:  Toxicol Appl Pharmacol       Date:  2004-08-01       Impact factor: 4.219

Review 9.  Oxidative stress as a possible mode of action for arsenic carcinogenesis.

Authors:  Kirk T Kitchin; Sarfaraz Ahmad
Journal:  Toxicol Lett       Date:  2003-01-31       Impact factor: 4.372

Review 10.  Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer.

Authors:  Margaret A Knowles; Fiona M Platt; Rebecca L Ross; Carolyn D Hurst
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

View more
  4 in total

1.  Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.

Authors:  Christina Michailidi; Masamichi Hayashi; Sayantan Datta; Tanusree Sen; Kaitlyn Zenner; Oluwadamilola Oladeru; Mariana Brait; Evgeny Izumchenko; Alexander Baras; Christopher VandenBussche; Maria Argos; Trinity J Bivalacqua; Habibul Ahsan; Noah M Hahn; George J Netto; David Sidransky; Mohammad Obaidul Hoque
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-13

Review 2.  Effects of arsenic toxicity beyond epigenetic modifications.

Authors:  Geir Bjørklund; Jan Aaseth; Salvatore Chirumbolo; Mauricio A Urbina; Riaz Uddin
Journal:  Environ Geochem Health       Date:  2017-05-08       Impact factor: 4.609

Review 3.  Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.

Authors:  Rita Nahta; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Rafaela Andrade-Vieira; Sarah N Bay; Dustin G Brown; Gloria M Calaf; Robert C Castellino; Karine A Cohen-Solal; Annamaria Colacci; Nichola Cruickshanks; Paul Dent; Riccardo Di Fiore; Stefano Forte; Gary S Goldberg; Roslida A Hamid; Harini Krishnan; Dale W Laird; Ahmed Lasfar; Paola A Marignani; Lorenzo Memeo; Chiara Mondello; Christian C Naus; Richard Ponce-Cusi; Jayadev Raju; Debasish Roy; Rabindra Roy; Elizabeth P Ryan; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Renza Vento; Jan Vondráček; Mark Wade; Jordan Woodrick; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

4.  LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.

Authors:  Tao Jiang; Xinxing Lu; Feiya Yang; Mingshuai Wang; Hua Yang; Nianzeng Xing
Journal:  FEBS Open Bio       Date:  2020-09-16       Impact factor: 2.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.